## AMGN: Amgen Inc. - XLV: Healthcare

### Executive Summary

VALUE thesis: PEG 1.03 indicates fundamental undervaluation. Quality metrics strong (ROE 82%). Consistent execution (4/4 quarters beat estimates). Caution: declining volume (59% of avg).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($308.76)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 7, Bearish: 0)

**1. D.A. Davidson & CO. Purchases 6,222 Shares of Amgen Inc. $AMGN**
- Source: MarketBeat | 20260105T141944 | Bullish | Relevance: 100%
- D.A. Davidson & CO. increased its stake in Amgen Inc. by 2.6% in the third quarter, purchasing 6,222 additional shares and bringing their total holdings to 243,054 shares valued at $68.59 million. This increase follows Amgen's strong quarterly earnings report, which exceeded analyst expectations, and a declared increase in its quarterly dividend to $2.52 per share. The article also details recent insider transactions and various analyst ratings for Amgen.

**2. Greenspring Advisors LLC Makes New $1.69 Million Investment in Amgen Inc. $AMGN**
- Source: MarketBeat | 20260105T133954 | Bullish | Relevance: 100%
- Greenspring Advisors LLC has initiated a new position in Amgen Inc. by purchasing 6,000 shares worth approximately $1.693 million, making it their 25th-largest holding. Amgen reported strong Q3 results, surpassing earnings expectations with $5.64 EPS, and has increased its quarterly dividend to $2.52 per share, yielding 3.1%. The company has also provided optimistic FY2025 guidance.

**3. Railway Pension Investments Ltd Has $27.18 Million Position in Amgen Inc. $AMGN**
- Source: MarketBeat | 20260105T122803 | Bullish | Relevance: 100%
- Railway Pension Investments Ltd significantly increased its stake in Amgen Inc. to $27.18 million, owning 96,300 shares, reflecting a 9.3% boost. Amgen reported strong Q3 earnings, surpassing estimates with $5.64 EPS on $9.56 billion revenue, and increased its quarterly dividend to $2.52 per share ($10.08 annualized). Analyst ratings average to a "Moderate Buy" with a consensus price target of $335.35, indicating positive sentiment despite some insider selling.

**4. Amgen (AMGN) price target trimmed at Morgan Stanley as policy risks ease**
- Source: MSN | 20260105T000803 | Somewhat-Bearish | Relevance: 100%
- Morgan Stanley has reportedly trimmed its price target for Amgen (AMGN), citing an easing of policy risks. This indicates a potential re-evaluation of the company's valuation based on a changing regulatory landscape.

**5. With 80% Ownership, Amgen Inc. (NASDAQ:AMGN) Boasts of Strong Institutional Backing**
- Source: 富途牛牛 | 20260104T160739 | Somewhat-Bullish | Relevance: 100%
- Institutional investors hold a substantial 80% stake in Amgen Inc. (NASDAQ:AMGN), indicating significant influence over its share price. While institutions like The Vanguard Group hold large portions, no single shareholder has a majority interest, with the top 18 shareholders controlling 50% of ownership. Over the past year, insiders have sold shares, and retail investors hold a 19% stake.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | Morgan Stanley | $304 | $329 | -8% |
| 2025-12-10 | Wells Fargo | $325 | $300 | +8% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | Morgan Stanley | main | Equal-Weight |
| 2025-12-10 | Wells Fargo | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.00M) |
| Sells | 7 ($2.74M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 10.0% (+0.3%)
- Blackrock Inc.: 8.6% (-1.2%)
- State Street Corpora: 5.4% (-0.2%)
- Capital Internationa: 3.6% (+1.5%)
- Capital World Invest: 3.5% (+11.5%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.03 suggests fair value with growth premium. Forward P/E 14.6x stretched relative to 3% growth. Quality metrics strong (ROE 82%, margin 20%). Balance sheet: $4.2B free cash flow. Insider selling cluster ($2.7M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $172.7B |
| Beta | 0.45 |
| 52W Range | $257.05 - $346.38 |
| Short Interest | 2.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.03 |
| Forward P/E | 14.6 |
| Current P/E | 15.1 |
| YoY Growth | 3.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -0.0% to -1.6% (-1.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.6pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.08x) but short-term weakness (below SMA20). MACD histogram bearish (-0.84), momentum weakening. RSI neutral at 42. Volume at 59% of 20MA suggests lack of conviction. OFD pattern: -MLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.60% (CS: 23) | Neutral |
| RSI_14 | 42.2 | Neutral |
| MACD Histogram | -0.84 | Bearish |
| vs SMA20 | 0.985x | Below |
| vs SMA50 | 0.989x | Below |
| vs SMA200 | 1.077x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $320.72
- **Stop Loss:** $308.76 (3.7% risk)
- **Target:** $344.64 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 72
- **Position Value:** $23,091.84
- **Portfolio %:** 23.09%
- **Risk Dollars:** $862.50
- **Risk Per Trade:** 0.86%
- **Modifiers:** L1 115% | L2 75% | Combined 0.86x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-02-03 (Est: $4.74)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $5.01 | $5.64 | +12.5% |
| 2025Q2 | $5.28 | $6.02 | +14.1% |
| 2025Q1 | $4.26 | $4.90 | +15.0% |
| 2024Q4 | $5.08 | $5.31 | +4.6% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_20*